Fundamentals of Hematopoietic Stem Cell Transplantation 2014

Grapevine, TX US
February 26, 2014 to February 27, 2014
Hematopoietic cell transplantation (HCT) is the only known curative therapy for many patients with hematologic malignancies and other blood, immune system, and metabolic disorders. In the United States each year, more than 20,000 HCTs are performed. As a result of advances in supportive care and transplantation techniques, this number is expected to increase significantly. HCT patients are on highly complex medication regimens and many of them are receiving long‐term follow up in the community. Practitioners working with HCT patients must be skilled in the management of transplant medication drug‐drug and drug‐food interactions, therapeutic drug monitoring, recognition and management of adverse effects, provision of supportive care, and selection of appropriate medications.
 
 
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical College of Wisconsin and the National Marrow Donor Program. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 16.25 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 


Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 16.25 hours of participation for continuing education for allied health professionals.
 
This meeting was supported by an Unrestricted Education Grant from Amgen.

Target Audience

  • Physicians
  • Fellows
  • Residents
  • Nurses
  • Pharmacists
  • NP/PAs

Learning Objectives

  1. Describe the advantages and disadvantages of the available strategies for stem cell mobilization 
  2. Outline commonly used preparative regimens, describing the expected toxicity profiles of the different approaches 
  3. Review the current challenges in the management of nausea and vomiting in the HCT population, and outline antiemetic strategies to minimize nausea and vomiting 
  4. Appraise the appropriateness of patient eligibility for HCT based on disease‐specific transplantation outcomes 
  5. Describe strategies available for disease control post HCT 
  6. Describe the management of common toxicities of HCT, including mucositis, nutritional statusrelated complications, and sinusoidal obstructive syndrome 
  7. Discuss the common bacterial pathogens, prophylaxis strategies, and treatment approaches in patients undergoing HCT 
  8. Review the incidence of invasive fungal infections in HCT patients, and describe treatment strategies (prophylaxis, empiric treatment, and treatment of documented fungal infections) in HCT patients 
  9. Discuss the incidence, prophylaxis, and treatment of common viral infections in HCT patients 
  10. Describe risk factors for, prevention strategies, treatment strategies, and common manifestations of acute graft‐versus‐host disease (GVHD) 
  11. Describe risk factors for, prevention strategies, treatment strategies, and common long term complications of chronic GVHD 
  12. Describe the common pulmonary complications associated with HCT, and identify common approaches to treatment of these complications 
  13. Review the long‐term complications associated with patient undergoing HCT
Additional information

CME Coordinator Contact Information

Name: 
Lyndsey Aspaas & Karen Mann
Phone Number: 
+1 (612) 627-5865
Email: 
laspaas@NMDP.org
Course summary
Available credit: 
  • 16.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 16.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
01/01/2014
Course expires: 
05/30/2014
Event starts: 
02/26/2014 - 8:00am
Event ends: 
02/27/2014 - 5:30pm
Cost:
$0.00
Add to calendar: 
Gaylord Texan Resort & Convention Center
1501 Gaylord Trail
Grapevine, TX 76501
United States
    Gaylord Texan Resort and Convention Center
    1501 Gaylord Trail, Grapevine, TX 76051
    (817) 778-1000
    Planning Committee:
    J. Douglas Rizzo, MD, MS
    Elizabeth Murphy, EdD, RN
    Lyndsey Aspaas, BS, CHTC
    Michael Westmoreland, PharmD, BCOP
    Terri Davidson, PharmD
    Julie Marino
    Helen Leather, BPharm
    Tracey Walsh-Chocolaad, PharmD
     
    Speakers:
    Zahra Mahmoudjafari, PharmD, BCOP
    Kristin Held, PharmD, BCOP
    Susie Liewer, PharmD, BCOP
    Sarah Perreault, PharmD, BCPS, BCOP
    Ryan Bookout, PharmD, BCPS, BCOP
    Alex Ganetsky, PharmD, BCOP
    Kamakshi Rao, PharmD, BCOP, CPP
    Valkal Bhatt, PharmD, BCOP
    Michael Westmoreland, PharmD, BCOP
    Susannah Koontz, PharmD, BCOP
    Patrick Kiel, PharmD, BCPS, BCOP
    James Hart, PharmD, BCOP
    Amber Bradley, PharmD, BCOP
    Amber Lawson, PharmD, BCOP
    Angela Hsieh, PharmD, BCOP
    Kelly Gregory, PharmD, BCOP
    Rebecca Tombleson, PharmD
     
     
     
    All persons in control of content have NO relevant financial relationships to disclose with the exception of the following person(s):
     
     

    Available Credit

    • 16.25 AMA PRA Category 1 Credit(s)™
      AMA PRA Category 1 Credit(s)™
    • 16.25 Hours of Participation
      Hours of Participation credit.

    Accreditation Period

    Course opens: 
    01/01/2014
    Course expires: 
    05/30/2014

    Price

    Cost:
    $0.00
    Please login or register to take this course.